Boston Scientific (NYSE: BSX) agreed a co-funding partnership with Blackstone Life Sciences to develop the VITALYST next-generation heart pump for cardiogenic shock. The VITALYST device marks the ...
Original Image Link
Source:finance.yahoo.com
Original Image Link
Source:finance.yahoo.com
Posted: 2026-11-03 02:01:00









